Long-term effects of unprovoked venous thromboembolism on mortality and major cardiovascular events

Comparative safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism - a Danish nationwide study

Validation of the prognostic impact of copeptin in normotensive pulmonary embolism in a european multicentre study.

A novel experimental in vivo model of acute pulmonary embolism

The YEARS algorithm for suspected pulmonary embolism leads to much shorter diagnostic turnaround time than conventional algorithms

Recurrent venous thromboembolism and major bleeding in patients treated with rivaroxaban or warfarin for venous thromboembolism in routine practice

Rivaroxaban prevents the development of chronic thromboembolic pulmonary hypertension in mice- Novel beneficial effects of the FXa inhibitor-